Related Experiment Videos
Budd-Chiari syndrome recurring in a transplanted liver
Gastroenterology
|March 1, 1983
Summary
Budd-Chiari syndrome recurrence after liver transplant is detailed. Antithrombotic therapy withdrawal led to vascular thromboses, sepsis, and death, highlighting the critical role of anticoagulation in post-transplant Budd-Chiari patients.
Area of Science:
- Hepatology
- Transplantation Surgery
- Vascular Thrombosis
Background:
- Budd-Chiari syndrome is a rare condition characterized by hepatic venous outflow obstruction.
- Orthotopic liver transplantation is a potential treatment for end-stage Budd-Chiari syndrome.
- Recurrence of Budd-Chiari syndrome post-transplantation presents significant management challenges.
Observation:
- A patient with Budd-Chiari syndrome underwent successful orthotopic liver transplantation.
- Postoperative period complicated by multiple thrombotic events.
- Remission achieved with coumadin and persantine therapy.
Findings:
- Discontinuation of antithrombotic therapy precipitated recurrent vascular thromboses.
- The patient developed sepsis and died 15 months post-transplantation.
- Autopsy confirmed recurrent Budd-Chiari syndrome and widespread thromboses.
Implications:
- This case underscores the critical importance of sustained antithrombotic therapy in preventing Budd-Chiari syndrome recurrence after liver transplantation.
- Aggressive management of thrombosis is essential in post-transplant patients with Budd-Chiari syndrome.
- Further research into optimal anticoagulation strategies for this patient population is warranted.